Kezar Life Sciences, Inc. (KZR) Return On Equity % [USD] 2018 - 2023

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kezar Life Sciences, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Kezar Life Sciences, Inc. Return On Equity for the quarter ending March 31, 2024 was -50.4 %, a 86.6% decline year-over-year.
  • Kezar Life Sciences, Inc. annual Return On Equity for 2023 was -45.9 %, a 82% decline from 2022.
  • Kezar Life Sciences, Inc. annual Return On Equity for 2022 was -25.2 %, a 32.3% increase from 2021.
  • Kezar Life Sciences, Inc. annual Return On Equity for 2021 was -37.2 %, a 27.6% decline from 2020.
Return On Equity, Annual (% [USD])
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -45.9 -20.7 -82% Jan 1, 2023 Dec 31, 2023
2022 -25.2 +12 +32.3% Jan 1, 2022 Dec 31, 2022
2021 -37.2 -8.06 -27.6% Jan 1, 2021 Dec 31, 2021
2020 -29.2 +9.67 +24.9% Jan 1, 2020 Dec 31, 2020
2019 -38.9 -9.12 -30.7% Jan 1, 2019 Dec 31, 2019
2018 -29.7 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.